Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 50001 Hradec Kralove, Czech Republic; Karel Englis College in Brno, Sujanovo namesti 356/1, 60200 Brno, Czech Republic.
Environ Toxicol Pharmacol. 2013 Nov;36(3):801-6. doi: 10.1016/j.etap.2013.07.012. Epub 2013 Jul 24.
HI-6 is used as an antidote to nerve agents. It can also act as an antagonist to acetylcholine receptors (AChRs) including the nicotinic receptor, α 7 nAChR which is involved in regulating the immune response through macrophages. This experiment investigated the efficacy of HI-6 to regulate the immune response. Laboratory BALB/c mice received HI-6 and/or keyhole limpet hemocyanin (KLH) as an antigen. Antibody production was investigated after either 21 or 65 days when either single or repeated dose of antigen was applied. We confirmed that HI-6 significantly improved vaccination efficacy when KLH was given in a dose of 1mg/kg. The effect was dose dependent. A combination of HI-6 and KLH produced a vaccination of almost the same efficacy as that for Freund's complete adjuvant. The findings point at the suitability of HI-6 for improving vaccination efficacy at the level of immunity regulation by the nervous system.
HI-6 可用作神经毒剂的解毒剂。它还可以作为乙酰胆碱受体(AChRs)的拮抗剂,包括参与通过巨噬细胞调节免疫反应的烟碱型受体(α7 nAChR)。本实验研究了 HI-6 调节免疫反应的功效。实验室 BALB/c 小鼠接受 HI-6 和/或血蓝蛋白(KLH)作为抗原。在单次或重复剂量的抗原应用 21 或 65 天后,研究了抗体的产生情况。我们证实,当 KLH 的剂量为 1mg/kg 时,HI-6 显著提高了疫苗接种的效果。这种效果是剂量依赖性的。HI-6 与 KLH 的组合产生的疫苗接种效果几乎与福氏完全佐剂相同。这些发现表明 HI-6 适合通过神经系统在免疫调节水平上提高疫苗接种的效果。